Tous Actualités
Suivre
Abonner Axxonis Pharma AG

Axxonis Pharma AG

Axxonis Pharma AG, has identified and patented several new chemical entities as neuroprotective agents

Berlin (ots)

The new compounds will provide a "full time"
protection of neurons against aging and degeneration. Continuous 
administration technologies, which are one of the core competencies 
of Axxonis Pharma AG, will additionally enable the concept of 24 
hours protection. This is a completely new and innovative approach in
radical scavenging therapy and in the therapy of neurological 
disorders induced by oxidative stress.
The new drugs in combination of non-invasive transdermal or 
minimal invasive (subcutaneous minipump) application methods will 
establish new potent neuroprotective therapies for patients suffering
from Parkinson´s disease, Alzheimer´s disease, Huntington´s disease, 
Amyotrophic Lateral Sclerosis or Multiple System Atrophy or other 
neurological degenerative diseases induced by chemical radicals.
Axxonis Pharma AG has recently submitted Lisuride transdermal and 
subcutaneous drug products (Nenad®) for centralized EU procedure for 
continuous dopaminergic stimulation therapy of M. Parkinson and 
related disorders. Lisuride is known as a potent radical scavenger 
both in vitro and in vivo with strong antioxidant and neuroprotective
effects in vulnerable CNS cell populations.
The new compounds which come from a joint research project, funded
in part with financial means from the EU, between the Institute of 
Pharmacy (Prof. H.H. Pertz) of the Freie Universität Berlin, Germany,
and Alfarma s.r.o., Cernosice, Czech Republic will extend 
significantly the portfolio of Axxonis Pharma AG and will 
substantiate long term growth.
Contact:

Pressekontakt:

Dr. med. Antje Müller-Schubert
Clinical Research & Medical Relations
axxonis Pharma AG
Schöneberger Straße 15
D - 10963 Berlin

phone: +49 (0)30 - 269 34 29 14
fax: +49 (0)30 - 269 34 29 22

a.mueller-schubert@axxonis.com

To learn more abaout axxonis:
www.axxonis.com
www.lisurid-cds.de